Page 17 - Pharma Companies
To end reliance on China, Indian pharma firms go local for raw materials
Though India is known as the pharmacy of the world for its massive production capacities of both generic drugs and vaccines, China accounted for half of its API needs in 2019
 "To end reliance on China, Indian pharma firms go local for raw materials")
Can re-engineer Covaxin to beat South African variant: Bharat Biotech
Other vaccine makers, such as Hyderabad-based Biological E, too, have started working on different strains.
 "Can re-engineer Covaxin to beat South African variant: Bharat Biotech")
Pfizer-BioNTech vaccine stops Covid-19 spread by 90%, says study
This provides the first indication that the immunisation will curb transmission
 "Pfizer-BioNTech vaccine stops Covid-19 spread by 90%, says study")
As Covid-19 cases fall, so do sales of favipiravir and remdesivir drugs
While remdesivir is an injectable drug which is administered in hospital settings, antiviral drug favipiravir is given orally
 "As Covid-19 cases fall, so do sales of favipiravir and remdesivir drugs")
Novavax, Serum Institute plans to supply 1.1 billion doses to COVAX
Novavax has signed a memorandum of understanding (MoU) in this regard with Gavi, the Vaccine Alliance.
 "Novavax, Serum Institute plans to supply 1.1 billion doses to COVAX")
States shying away from administering Bharat Bio's Covid-19 vaccine Covaxin
A month on, 21 states and UTs have not administered a single shot of the vaccine
 "States shying away from administering Bharat Bio's Covid-19 vaccine Covaxin")
Pharma's 3Q profitability improvement starts to taper off: Ind-Ra
The ratings agency does not expect Indian pharmaceutical companies to sustain the healthy operating margins reported during 3Q FY21 and 9M FY21
 "Pharma's 3Q profitability improvement starts to taper off: Ind-Ra")
AstraZeneca Pharma India Q3 net profit declines 21% at Rs 21 crore
Drug firmAstraZeneca Pharma India on Monday reported a 21 per cent decline in net profit at Rs 21.05 crore for the quarter ended in December
 "AstraZeneca Pharma India Q3 net profit declines 21% at Rs 21 crore")
Corporate air travel takes wing on economic revival, low Covid-19 cases
Online travel portals and airlines say the demand from companies is being led by essential services sectors like pharmaceutical, oil and gas, and power
 "Corporate air travel takes wing on economic revival, low Covid-19 cases")
Sales of Ivermectin, drug to treat parasitic infections, jump fourfold
Mumbai-based pulmonologist Dr Agam Vora said in the first few months of the pandemic, the line of treatment was not established
 "Sales of Ivermectin, drug to treat parasitic infections, jump fourfold")
Active pharmaceutical ingredients sales momentum begins to normalise
With API supply, especially from China, facing some constraints because of lockdowns in several countries, demand from global clients had shot up for Indian players
 "Active pharmaceutical ingredients sales momentum begins to normalise")
Zydus Cadila's Q3 net up 41% to Rs 527 cr on strong India biz growth
US formulations business dips 4% with revenues at Rs 1,603 cr, Q3 sees Zydus file 10 additional ANDAs with US FDA, taking total filings to 410
More Covid-19 vaccine candidates get approval for clinical trials in India
As for Bharat Biotech's chimpanzee flu virus (adenovirus) based intra-nasal vaccine candidate, the SEC recommended grant of permission for phase I trials
 "More Covid-19 vaccine candidates get approval for clinical trials in India")
More Covid-19 vaccine candidates get approval for clinical trials in India
As for Bharat Biotech's chimpanzee flu virus (adenovirus) based intra-nasal vaccine candidate, the SEC recommended grant of permission for phase I trials
Regeneron Pharmaceuticals quarterly profit beats on strong drug sales
Regeneron's antibody cocktail garnered $145.5 million in sales for the fourth quarter. While, the consensus Wall Street estimate was $173 million, according to Guggenheim analyst Yatin Suneja.
 "Regeneron Pharmaceuticals quarterly profit beats on strong drug sales")
Pfizer retracts request for emergency approval of Covid-19 vaccine in India
Pfizer has not conducted any bridge trial on Indian population for its mRNA vaccine
 "Pfizer retracts request for emergency approval of Covid-19 vaccine in India")
US drugmaker Merck's Kenneth Frazier to step down as CEO in June-end
Frazier, 66, will remain with the drugmaker as executive chairman for a transition period to be determined by the board.
 "US drugmaker Merck's Kenneth Frazier to step down as CEO in June-end")
Novavax Covid-19 vaccine shows 89% efficacy in UK clinical trials
The trial has assessed its efficacy during a period with high transmission and with a new UK strain of the virus
World Coronavirus Dispatch: Pharma giants not prepared for next pandemic
World cases cross 100 mn, Italian politics and Dutch protests add to Europe's Covid woes, Japan wants domestic trials before vaccine roll-out and other pandemic-related news across the globe
 "World Coronavirus Dispatch: Pharma giants not prepared for next pandemic")
Serum Institute looking at bilateral deals to supply Covishield vaccine
To raise manufacturing capacity by 30% over next 2 months from present 2.4 mn doses
 "Serum Institute looking at bilateral deals to supply Covishield vaccine")
